David James Lennon
Director, CHIEF EXECUTIVE OFFICER · 4 filings · Latest: May 14, 2026
Whitehawk Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
WHWK | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | May 14, 2026 | Grant/Award | $3.92 | 51,021 | $200.0K | 569,643 | |
WHWK | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Apr 9, 2026 | Sale | $3.38 | 14,500 | $49.0K | 518,622 | |
WHWK | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Apr 8, 2026 | Sale | $3.40 | 63,945 | $217.4K | 533,122 | |
WHWK | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Apr 7, 2026 | Sale | $3.43 | 94,087 | $322.7K | 597,067 | |
WHWK | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Apr 6, 2026 | Sale | $3.51 | 102,395 | $359.4K | 691,154 | |
WHWK | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Apr 2, 2026 | Sale | $3.48 | 26,858 | $93.5K | 793,549 | |
WHWK | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Apr 1, 2026 | Option Exercise | — | 775,828 | — | 820,407 |